Dr. Kelly Wei Joins NVE Corporation's Board of Directors
Dr. Kelly Wei Joins NVE Corporation's Board of Directors
EDEN PRAIRIE, Minn., May 13, 2024 (GLOBE NEWSWIRE) -- NVE Corporation (Nasdaq: NVEC) announced today that its Board of Directors elected Kelly Wei, Ph.D. to join the Board, effective today, filling the unexpired term of Richard W. Kramp, who passed away recently. Dr. Wei will also serve on the Board's Compensation Committee and Nominating and Corporate Governance Committee.
明尼蘇達州伊甸草原，2024年5月13日（環球新聞專線）——NVE公司（納斯達克股票代碼：NVEC）今天宣佈，其董事會選舉凱利·魏博士加入董事會，從今天起生效，填補最近去世的Richard W. Kramp的未滿任期。魏博士還將在董事會的薪酬委員會和提名與公司治理委員會任職。
Mr. Kramp's unexpired term ends at NVE's 2024 annual shareholders' meeting. The Board expects to nominate Dr. Wei for a full term at that shareholders' meeting.
克蘭普先生的未到期任期在NVE的2024年年度股東大會上結束。董事會預計將在該次股東大會上提名魏博士任滿任期。
"We are pleased to welcome Dr. Kelly Wei to our Board," said NVE President and Chief Executive Officer Daniel A. Baker, Ph.D. "Her strong management, technical, and medical device experience, and her engineering and medical education make her exceptionally qualified to serve as a director."
“我們很高興歡迎魏凱利博士加入我們的董事會，” NVE總裁兼首席執行官丹尼爾·貝克博士說，“她豐富的管理、技術和醫療器械經驗以及工程和醫學教育使她非常有資格擔任董事。”
Dr. Wei is Vice President of Corporate Strategy at Medtronic plc. She has held various scientific, engineering, management, and senior management positions at Medtronic since 2007. Dr. Wei started her career as a senior research scientist in cardiac rhythm and disease management at Boston Scientific Corporation in 2004. She has been a member of the Board of Trustees of the Williams Syndrome Association since 2021, and a member of the Board of Directors of Abova, Inc. since February 2024. Abova is a privately-held oral and overall health, technology and science-driven company. She is also a certified executive coach. Dr. Wei has a Ph.D. in Electrical Engineering and an M.S. in Computer Engineering from Rensselaer Polytechnic Institute, an M.S. in Integrative Biology and Physiology from the University of Minnesota Medical School, and a B.S. in Electrical Engineering from Huazhong University of Science and Technology.
魏博士是美敦力集團的企業戰略副總裁。自2007年以來，她在美敦力擔任過各種科學、工程、管理和高級管理職位。魏博士於 2004 年在波士頓科學公司擔任心律和疾病管理高級研究科學家，開始了她的職業生涯。她自 2021 年起擔任威廉綜合症協會董事會成員，自 2024 年 2 月起擔任 Abova, Inc. 的董事會成員。Abova是一傢俬人控股的口腔和整體健康、技術和科學驅動的公司。她還是一名認證的高管教練。魏博士擁有倫斯勒理工學院電氣工程博士學位和計算機工程碩士學位、明尼蘇達大學醫學院綜合生物學和生理學碩士學位以及華中科技大學電氣工程學士學位。
NVE is a leader in the practical commercialization of spintronics, a nanotechnology that relies on electron spin rather than electron charge to acquire, store, and transmit information. The company manufactures high-performance spintronic products including sensors and couplers that are used to acquire and transmit data.
NVE 是自旋電子學實際商業化的領導者，自旋電子學是一種依靠電子自旋而不是電子電荷來獲取、存儲和傳輸信息的納米技術。該公司生產高性能的自旋電子產品，包括用於採集和傳輸數據的傳感器和耦合器。
Statements used in this press release that relate to future plans, events, financial results, or performance are forward-looking statements that are subject to certain risks and uncertainties including the risk factors listed from time to time in our filings with the SEC, including our Annual Report on Form 10-K for the fiscal year ended March 31, 2024.
本新聞稿中使用的與未來計劃、事件、財務業績或業績相關的陳述均爲前瞻性陳述，存在某些風險和不確定性，包括我們在向美國證券交易委員會提交的文件（包括截至2024年3月31日財年的10-K表年度報告）中不時列出的風險因素。
###
###
CONTACT: Daniel A. Baker, President and CEO, 952-829-9217
聯繫人：丹尼爾·貝克，總裁兼首席執行官，952-829-9217
譯文內容由第三人軟體翻譯。